Institute of Oncology of Southern Switzerland
Bellinzona 6500
0 studies enrolling now · 1 studies all time
What they study most
HER2 Positive Breast Cancer
Studies at this site
A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer
— Completed